BRIDGEBIO PHARMA

BridgeBio is a biotechnology company that focuses on genetic disease therapies and develops those assets with the right approach in supporting R&D. BridgeBio creates a bridge from advancements in genetic science to patients with unmet needs via the entrepreneurial engine required to make life-changing medicines as rapidly as possible. BridgeBio's mission is to discover, create, test, and deliver transformative medicines to treat patients with genetic diseases.

#People #Financial #Website #More

BRIDGEBIO PHARMA

Social Links:

Twitter

Industry:

Biotechnology Health Care Life Science Medical Pharmaceutical

Founded:

2014-01-01

Address:

Palo Alto, California, United States

Country:

United States

Website Url:

http://www.bridgebio.com

Total Employee:

251+

Status:

Active

Contact:

650-391-9740

Email Addresses:

[email protected]

Total Funding:

1.95 B USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Google Tag Manager WordPress Domain Not Resolving Apache

Current Advisors List

randy-scott_image

Randy Scott Director Board Of Directors @ BridgeBio Pharma
Board_member
2020-06-01

laura-a-brege_image

Laura A. Brege Senior Advisor @ BridgeBio Pharma
Advisor
2017-04-01

Current Employees Featured

neil-kumar_image

Neil Kumar
Neil Kumar Co-Founder & CEO @ BridgeBio Pharma
Co-Founder & CEO
2014-09-01

justin-to_image

Justin To
Justin To VP of Business Development and Operations, Gene Therapy @ BridgeBio Pharma
VP of Business Development and Operations, Gene Therapy
2018-03-01

michael-pettigrew_image

Michael Pettigrew
Michael Pettigrew VP, Asset Acquisition @ BridgeBio Pharma
VP, Asset Acquisition
2016-08-01

not_available_image

Uma Sinha
Uma Sinha Chief Scientific Officer @ BridgeBio Pharma
Chief Scientific Officer
2016-04-01

eli-m-wallace_image

Eli M. Wallace
Eli M. Wallace Chief Scientific Officer In Residence @ BridgeBio Pharma
Chief Scientific Officer In Residence
2019-12-01

christine-siu_image

Christine Siu
Christine Siu Chief Operating Officer @ BridgeBio Pharma
Chief Operating Officer
2020-01-01

josh-loehrer_image

Josh Loehrer
Josh Loehrer SVP, People @ BridgeBio Pharma
SVP, People
2021-02-01

frank-mccormick_image

Frank McCormick
Frank McCormick Co-founder @ BridgeBio Pharma
Co-founder
2015-12-01

ali-panjwani_image

Ali Panjwani
Ali Panjwani Director, Pricing & Contracting, Market Access @ BridgeBio Pharma
Director, Pricing & Contracting, Market Access

caroline-landau_image

Caroline Landau
Caroline Landau Director and Gene Therapy Product Planning @ BridgeBio Pharma
Director and Gene Therapy Product Planning
2021-10-01

Founder

frank-mccormick_image

Frank McCormick

neil-kumar_image

Neil Kumar

Stock Details

Company's stock symbol is NASDAQ:BBIO

Acquisitions List

Date	Company	Article	Price
2020-10-05	Eidos Therapeutics	Eidos Therapeutics acquired by BridgeBio Pharma	175 M USD

Investors List

perceptive-advisors_image

Investments List

Date	Company	Article	Money raised
2018-04-05	Eidos Therapeutics	BridgeBio Pharma investment in Series B - Eidos Therapeutics	64 M USD
2018-01-30	QED Therapeutics	BridgeBio Pharma investment in Venture Round - QED Therapeutics	65 M USD
2017-08-01	PellePharm	BridgeBio Pharma investment in Series B - PellePharm	20 M USD
2015-04-30	MyoKardia	BridgeBio Pharma investment in Series B - MyoKardia	46 M USD
2014-08-22	MyoKardia	BridgeBio Pharma investment in Venture Round - MyoKardia	10 M USD

Official Site Inspections

http://www.bridgebio.com Semrush global rank: 2.1 M Semrush visits lastest month: 9.77 K

Host Informations
Whois Informations

Loading ...